Target intelligence / Profile preview

RNA, U4 small nuclear 13, pseudogene (RNU4-13P)

Target
RNU4-13P
Molecular classification
Pseudogene, Non-coding RNA, Small nuclear RNA (snRNA) pseudogene
01

Overview

RNA, U4 small nuclear 13, pseudogene (RNU4-13P) is a human gene classified as a pseudogene of the U4 small nuclear RNA (snRNA) family[1][6]. Unlike functional snRNAs, which are core components of the spliceosome complex essential for pre-mRNA splicing, pseudogenes like RNU4-13P are typically non-functional remnants arising from gene duplication or retrotransposition events and generally do not encode active RNA molecules or proteins[1][6]. There is no evidence implicating RNU4-13P in cellular function, disease, or therapeutic modulation; it does not appear in drug target databases and has no reported interacting drugs, biomarkers, or safety concerns[1][6]. Clarification: Recent neurodevelopmental disorder (NDD) research centers on a different small nuclear RNA gene, RNU4-2, which encodes the functional U4 snRNA subunit of the spliceosome and is implicated in disease when mutated[4][5][7][8][9]. However, these findings do not apply to RNU4-13P, which remains a non-functional pseudogene without any known role in splicing, disease, or therapy.

Other names
RNU4-13PRNA, U4 small nuclear 13, pseudogene
02

Mechanism of action

None

03

Biological functions

None (pseudogene; no known biological function)
04

Disease associations

None (no reported disease association)
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, U4 small nuclear 13, pseudogene (RNU4-13P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 13, pseudogene (RNU4-13P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call